Pages that link to "Q36053046"

The following pages link to Novel roles for acylation stimulating protein/C3adesArg: a review of recent in vitro and in vivo evidence (Q36053046):

Displaying 29 items.

• C5L2 is a functional receptor for acylation-stimulating protein (Q24300165) (← links)
• Association of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects. (Q30384917) (← links)
• Relationship between a novel polymorphism of the C5L2 gene and coronary artery disease (Q33940989) (← links)
• Complement alternative pathway activation in human nonalcoholic steatohepatitis (Q34317685) (← links)
• Recombinant acylation stimulating protein administration to C3-/- mice increases insulin resistance via adipocyte inflammatory mechanisms (Q34442404) (← links)
• Levels of acylation stimulating protein and the complement component 3 precursor are associated with the occurrence and development of coronary heart disease (Q34443992) (← links)
• C5a receptor deficiency alters energy utilization and fat storage (Q34717283) (← links)
• Downregulation of complement C3 and C3aR expression in subcutaneous adipose tissue in obese women (Q35151778) (← links)
• Rosiglitazone decreases postprandial production of acylation stimulating protein in type 2 diabetics (Q35808559) (← links)
• Lutein Leads to a Decrease of Factor D Secretion by Cultured Mature Human Adipocytes (Q36173190) (← links)
• Treatment of dyslipidemia in children and adolescents (Q36300178) (← links)
• Regulation of postprandial lipemia: an update on current trends (Q36749246) (← links)
• Type 2 diabetes and cardiovascular disease: getting to the fat of the matter (Q36814772) (← links)
• Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice (Q37264601) (← links)
• A complement-dependent balance between hepatic ischemia/reperfusion injury and liver regeneration in mice (Q37286701) (← links)
• A novel polymorphism (901G > a) of C5L2 gene is associated with coronary artery disease in Chinese Han and Uyghur population (Q37363125) (← links)
• Association of C5L2 genetic polymorphisms with coronary artery disease in a Han population in Xinjiang, China (Q37702759) (← links)
• Diagnosis and management of familial dyslipoproteinemias (Q38105993) (← links)
• Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice (Q38294970) (← links)
• Short- and Long-Term Effects of Weight Loss on the Complement Component C3 After Laparoscopic Gastric Bypass in Obese Patients. (Q38809764) (← links)
• The ASP receptor C5L2 is regulated by metabolic hormones associated with insulin resistance (Q40140325) (← links)
• Relationships among acylation-stimulating protein, insulin resistance, lipometabolism, and fetal growth in gestational diabetes mellitus women (Q40896188) (← links)
• Association of acylation-stimulating protein and receptor gene polymorphisms with coronary heart disease in Han and Hui populations (Q41569106) (← links)
• Visfatin expression is hormonally regulated by metabolic and sex hormones in 3T3-L1 pre-adipocytes and adipocytes (Q42827166) (← links)
• Increased acylation stimulating protein levels in young obese males is correlated with systemic markers of oxidative stress (Q50999771) (← links)
• Relationship between type 2 diabetes mellitus and a novel polymorphism C698T in C5L2 in the Chinese Han population. (Q54333432) (← links)
• Adiposopathy: why do adiposity and obesity cause metabolic disease? (Q56567724) (← links)
• Plasma Adipokine and Hormone Changes in Mountaineers on Ascent to 5300 Meters (Q57100406) (← links)
• Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis (Q58603887) (← links)